660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update.
Saved in:
| Title: | 660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update. |
|---|---|
| Authors: | Choueiri, T.K.1 (AUTHOR), Eto, M.2 (AUTHOR), Kopyltsov, E.3 (AUTHOR), Rha, S.Y.4 (AUTHOR), Porta, C.G.5 (AUTHOR), Motzer, R.6 (AUTHOR), Grünwald, V.7 (AUTHOR), Hutson, T.E.8 (AUTHOR), Méndez-Vidal, M.J.9 (AUTHOR), Hong, S-H.10 (AUTHOR), Winquist, E.11 (AUTHOR), Goh, J.C.H.12 (AUTHOR), Maroto, P.13 (AUTHOR), Buchler, T.14 (AUTHOR), Takagi, T.15 (AUTHOR), Rodriguez-Lopez, K.16 (AUTHOR), Xing, D.17 (AUTHOR), Smith, A.D.18 (AUTHOR), Powles, T.19 (AUTHOR) |
| Source: | Annals of Oncology. 2021 Supplement 5, Vol. 32, pS683-S685. 3p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2021.08.056 |
